Snap diagnosis of fulminant type 1 diabetes by the normalized glucose/HbA1c ratio

Endocr J. 2024 Nov 1;71(11):1093-1096. doi: 10.1507/endocrj.EJ24-0226. Epub 2024 Aug 10.

Abstract

Elevated Fulminant Index (FI), [plasma glucose (PG)/glycosylated hemoglobin A1c (HbA1c)], was reportedly a sensitive index to differentiate fulminant type 1 diabetes (FT1D) from non-fulminant T1D (nFT1D). Aim of this study was to describe a better, but simpler index of FT1D. 49 and 52 patients with FT1D and nFT1D, respectively, were registered, and the discriminating ability of the rounded, normalized ratio, [PG (mmol/L) - 5.0]/[HbA1c (%) - 5.0], and the original ratio, [PG (mmol/L)]/[HbA1c (%)], was compared. Normalizing the ratio significantly raised its accuracy: area under the curve for receiver operating curve, AUROC (95%CI), 0.927 (0.858-0.964) and 0.851 (0.763-0.910), respectively, with and without the normalization (p < 0.01). Rounding of the figure into [PG (mmol/L) - 5.0]/[HbA1c (%) - 5.0] did not significantly sacrifice the discriminating ability of the index. Namely, the optimal cut point of rounded and normalized GAR, 10.0, showed 89.8% sensitivity. In conclusion, rounded, normalized (rn) GAR ≥10 (the rounded optimal cut-off) could be used for the snap diagnosis of FT1D.

Keywords: Diagnosis; Fulminant type 1 diabetes; Ketoacidosis.

MeSH terms

  • Adolescent
  • Adult
  • Blood Glucose* / analysis
  • Blood Glucose* / metabolism
  • Child
  • Diabetes Mellitus, Type 1* / blood
  • Diabetes Mellitus, Type 1* / diagnosis
  • Diagnosis, Differential
  • Female
  • Glycated Hemoglobin* / analysis
  • Glycated Hemoglobin* / metabolism
  • Humans
  • Male
  • Middle Aged
  • Sensitivity and Specificity
  • Young Adult

Substances

  • Glycated Hemoglobin
  • Blood Glucose
  • hemoglobin A1c protein, human